Long-term outcomes of lung cancer screening in males and females

Ruggirello, Margherita; Valsecchi, Camilla; Ledda, Roberta Eufrasia; Sabia, Federica; Vigorito, Raffaella; Sozzi, Gabriella; Pastorino, Ugo

doi:10.1016/j.lungcan.2023.107387

Lung Cancer

2023

DOI: 10.1016/j.lungcan.2023.107387

|View full text |Cite

Long-term outcomes of lung cancer screening in males and females

Margherita Ruggirello,

Camilla Valsecchi,

Roberta Eufrasia Ledda

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The pros and cons of lung cancer screening

Ledda,

Funk,

Sverzellati

2024

Eur Radiol

View full text Add to dashboard Cite

Several trials have shown that low-dose computed tomography-based lung cancer screening (LCS) allows a substantial reduction in lung cancer-related mortality, carrying the potential for other clinical benefits. There are, however, some uncertainties to be clarified and several aspects to be implemented to optimize advantages and minimize the potential harms of LCS. This review summarizes current evidence on LCS, discussing some of the well-established and potential benefits, including lung cancer (LC)-related mortality reduction and opportunity for smoking cessation interventions, as well as the disadvantages of LCS, such as overdiagnosis and overtreatment. Clinical relevance statement Different perspectives are provided on LCS based on the updated literature. Key Points Lung cancer is a leading cancer-related cause of death and screening should reduce associated mortality. This review summarizes current evidence related to LCS. Several aspects need to be implemented to optimize benefits and minimize potential drawbacks of LCS.

show abstract

The pros and cons of lung cancer screening

Ledda,

Funk,

Sverzellati

2024

Eur Radiol

View full text Add to dashboard Cite

show abstract

The Pivotal Role of Baseline LDCT for Lung Cancer Screening in the Era of Artificial Intelligence

De Luca,

Diciotti,

Mascalchi

2024

Archivos de Bronconeumología

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Long-term outcomes of lung cancer screening in males and females

Cited by 2 publications

References 46 publications

The pros and cons of lung cancer screening

The pros and cons of lung cancer screening

The Pivotal Role of Baseline LDCT for Lung Cancer Screening in the Era of Artificial Intelligence

Contact Info

Product

Resources

About